Cite
HARVARD Citation
Kawajiri, H. et al. (2015). Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer. Expert review of anticancer therapy. 15 (1), pp. 17-26. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kawajiri, H. et al. (2015). Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer. Expert review of anticancer therapy. 15 (1), pp. 17-26. [Online].